Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing -- Ignore unavailable to you. Want to Upgrade?

To: Sun Tzu who wrote (8241)	3/15/2024 5:57:28 PM
From: Sun Tzu	Read Replies (1) \| Respond to of 10744

Shares of Cardlytics, Inc. CDLX rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings. Cardlytics posted adjusted earnings of 14 cents per share, beating market estimates of 12 cents per share, according to data from Benzinga Pro. The company said it sees first-quarter revenue of $70 million to $73 million, versus expectations of $66.46 million. Cardlytics shares jumped 36.6% to $11.18 in pre-market trading

To: Sun Tzu who wrote (8241)

9/19/2024 7:41:56 PM

From: Sun Tzu

Read Replies (1) | Respond to of 10744

From: Sun Tzu 3/15/2024 5:11:50 PM
Read Replies (1) of 8839

Aquestive Therapeutics AQST said its sublingual film epinephrine experimental drug Anaphylm showed exposure levels comparable to autoinjectors and was quicker to reach maximum concentration in a phase 3 study. Aquestive Therapeutics was up almost 2% pre-bell.

=====

JMP Securities Adjusts Price Target on Aquestive Therapeutics to $10 From $8, Maintains Market Outperform Rating
Mar 15, 202409:44 EDT

AQST+16.00%
Aquestive Therapeutics AQST has an average buy rating and price target range of $7 to $10, according to analysts polled by Capital IQ.

.
.
.

.
.
The analysts raised their price target at the top.
But me, being ignorant of such matters, there were 10 purchases ranging from single digit starters to double, triple, and quad digits as the trend got clearer.

That's all.